

<h3>Bibliografía</h3>

    <ol>
        <li>Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 2001; 86(5):1327-30.</li>
        <li>Hellum M, Øvstebø R, Brusletto BS, Berg JP, Brandtzaeg P, Henriksson CE. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock. Thromb Res 2014; 133(3):507-14.</li> 
        <li>Liaw PC, Ito T, Iba T, Thachil J, Zeerleder S. DAMP and DIC: The role of extracellular DNA and DNA binding proteins in the pathogenesis of DIC. Blood Reviews 2016; 30:257-61.</li>
        <li>Di Nisio M, Thachil J, Squizzato A. management of disseminated intravascular coagulation: A survey of the International Society on Thrombosis and Haemostasis. Thromb Res 2015; 136:239-42.</li>
        <li>García Frade LJ, Lorente JA, García Avello A, de Pablo R, Landín L. Plasminogen activator-1 levels determine the profibrinolytic response in disseminated intravascular coagulation. Am J Hematol 1992; 41:303-4.</li>
        <li>Levi M, Toth CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Brit J Haematol 2009;145:24-33.</li>
        <li>Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, Ikeda T, et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 2008;36(1):145-50.</li>
        <li>Erez, O. Disseminated intravascular coagulation in pregnancy - Clinical phenotypes and diagnostic scores. Thromb Res 2017; 151(Supl 1):56-60.</li>
        <li>Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, Ten Cate H, Thachil J, et al. Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thromb Haemost 2016;115(5):896-904.</li> 
        <li>Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286(15):1869-78.</li>
        <li>Iba T, Gando S, Saitoh D, Wada H, Di Nisio M, Thachil J. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation. Thromb Res 2016;145:46-50.</li>
        <li>Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Prowess-Shock Study Group: Drotecogin alfa (activated) in adults with septic shock. N Engl J Med 2012;366:2055-64.</li>
    </ol>